Navigation Links
Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes'
Date:2/19/2008

NEW YORK, Feb. 19 /PRNewswire/ -- On November 5, 2007, under increasing government pressure, Bayer Pharmaceuticals Corporation said that it had halted worldwide sales of its drug Trasylol after a Canadian clinical study found the drug could be linked to a higher risk of death than other drugs. The Food and Drug Administration asked the company to stop selling the drug, used to prevent excessive bleeding during heart bypass surgery, pending detailed review of preliminary results from the Canadian study.

In the wake of Bayer's announcement that it was pulling its controversial heart surgery drug Trasylol from the market, nationally known plaintiff's advocates Napoli Bern & Associates, LLP commenced several litigations seeking damages for a heart patient's death. One of those litigations, arising from the death of Joseph Randone, was profiled by CBS's "60 Minutes" on Sunday, February 17, 2008. In that story, renowned medical researcher Dr. Dennis Mangano calculated that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago, when his study revealed widespread death associated with it. Dr. Mangano also told 60 Minutes correspondent Scott Pelley that Bayer, the drug's maker, failed to tell the FDA about negative results of their own Trasylol study and that the company's failure to fully apprise the FDA of their own study's findings placed the drug's success before patient well-being.

The Randone case (Josephine Randone, Executrix Of The Estate Of Joseph Randone, And Josephine Randone, Individually, v. Bayer Corporation, et al.) was filed by Napoli Bern & Associates, LLP, and arises from horrific post- surgical complications suffered by Joseph Randone, a 52-year-old man who suffered kidney failure leading to a chain reaction resulting in his death following routine valve replacement surgery where Trasylol was utilized. Attorney Marc Jay Bern says, "the importance of the Trasylol
'/>"/>

SOURCE Napoli Bern & Associates, LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
2. Trasylol Pulled From Worldwide Market
3. Bayer Temporarily Suspends Global Trasylol(R) Marketing
4. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
5. CryoCath Provides Update on Patent Infringement Lawsuit
6. More Women File Lawsuits Against Dallas Presbyterian Hospital in Eating Disorders Fraud Case
7. Abbey Spanier Rodd & Abrams, LLP Files Class Action Lawsuit on Behalf of Purchasers of American Dental Partners, Inc. Securities
8. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
9. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
10. The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency
11. Hollywood Presbyterian Medical Center Responds to ACLU Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Marine threats from human or natural agents ... and international criminal and piracy threats have created ... systems. Due to this the worldwide revenue of ... 2014 and is expected to reach $20.87 billion ... expected to grow at a CAGR of 8.40%. ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, 2014 (HealthDay ... survival and the course of the disease in people with ... researchers report. , , The components in the blood that ... called albumin and creatinine. These components are normally tested to ... Library of Medicine. But now it appears that these ...
(Date:7/22/2014)... Virginia Commonwealth University has received a five-year, $3 ... as severe illnesses, neglect and maltreatment during childhood ... risks later in life. , The Center for ... School of Pharmacy, in collaboration with Duke University ... which is funded by the National Institutes of ...
(Date:7/22/2014)... Scientists attached radio-frequency identification (RFID) tags to hundreds of ... effort yielded two discoveries: Some foraging bees are much busier ... take their place. , The findings are reported ... bees revealed that about 20 percent of the foraging bees ... nectar and pollen gathered to feed the hive. , "We ...
(Date:7/22/2014)... Today, Therapy Changes announces the start of their Teen ... help increase their knowledge and ability to cope with life’s ... to make healthy and positive decisions while connecting with like-minded ... but also a time of major life transition and stress,” ... . , “Teens can at times feel misunderstood, so rather ...
Breaking Medicine News(10 mins):Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2Health News:Radio frequency ID tags on honey bees reveal hive dynamics 2Health News:Therapy Changes Announces Teen Support Group Therapy 2
... M. Jackson Foundation for the Advancement of Military Medicine, ... anesthesiology residents in the art and science of advanced ... aim is to serve as a resource to manage ... Military Advanced Regional Anesthesia and Analgesia Handbook " is ...
... Net and Elderly Care in Underserved Communities , ... announced today that it has approved more than 400 ... first quarter of 2009. The not-for-profit health care organization,s ... care in the safety net and improving care for ...
... promoting a painless new method for detecting diabetes, ... at the American Association of Clinical Endocrinologists (AACE) ... Texas.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ... diabetes, doctors examined the saliva of 40 different ...
... Non Dues Revenue for the Texas Medical ... launched MedBuzz, a powerful new online advertising ... Medical Association that has extended TMA,s online ... generated incremental non-dues revenue for the largest ...
... April 28 MinuteClinic, the pioneer and largest ... States, announced that it has become a participating ... insurer in Pennsylvania based on membership.Members of Highmark,s ... care centers located inside select CVS/pharmacy stores in ...
... SARS, and true severity of outbreak still unknown , , TUESDAY, April ... flu in Mexico rises and new cases appear in the United ... sense of mounting dread. , But experts in influenza and infectious ... still far from certain. , "This is something of concern [but] ...
Cached Medicine News:Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 3Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 4Health News:Detecting Diabetes Without a Needle: The Spit Factor 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 3Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 2Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 3Health News:Experts Say Panic Over Swine Flu Is Premature 2Health News:Experts Say Panic Over Swine Flu Is Premature 3Health News:Experts Say Panic Over Swine Flu Is Premature 4Health News:Experts Say Panic Over Swine Flu Is Premature 5
(Date:7/22/2014)... , July 22, 2014 /PRNewswire-iReach/ -- Reproductive ... New York ), a nationally and internationally-recognized ... patients requiring reproductive assistance, is pleased to announce a ... and Compassionate Care Programs to recognize the sacrifices made ... The Compassionate Corps Program will allow qualifying veterans ...
(Date:7/22/2014)... 2014 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: ... Directors has appointed Charles J. (Chuck) Bramlage ... of the Board.  Mr. Bramlage is ... marketing, sales and other commercial functions.  He is currently ... development stage company that was recently acquired by AstraZeneca ...
(Date:7/22/2014)... 22, 2014  NeuroSigma, Inc. (NeuroSigma), a ... of its non-invasive Monarch ™ eTNS™ Therapy ... today announced that enrollment has begun in a pediatric ... as adjunctive therapy for the treatment of Lennox-Gastaut Syndrome ... the Olive View-UCLA Medical Center in Sylmar, ...
Breaking Medicine Technology:Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 2BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 3BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 4BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 5BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 6BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors 7Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Minus cylinders only trial lens set....
Full Trial Lens Set....
Medicine Products: